Mary Mosher

Array ( [id] => 637711 [patent_doc_number] => 07125706 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-24 [patent_title] => 'Method for the production and purification of adenoviral vectors' [patent_app_type] => utility [patent_app_number] => 09/880609 [patent_app_country] => US [patent_app_date] => 2001-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 72 [patent_no_of_words] => 54917 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/125/07125706.pdf [firstpage_image] =>[orig_patent_app_number] => 09880609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6015574 [patent_doc_number] => 20020102533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Hepatitis C protease exosite for inhibit or design' [patent_app_type] => new [patent_app_number] => 09/878579 [patent_app_country] => US [patent_app_date] => 2001-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9056 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20020102533.pdf [firstpage_image] =>[orig_patent_app_number] => 09878579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6063476 [patent_doc_number] => 20020031823 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-14 [patent_title] => 'Use of trans-activation and CIS-activation to modulate the persistence of expression of a transgene' [patent_app_type] => new [patent_app_number] => 09/873486 [patent_app_country] => US [patent_app_date] => 2001-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10887 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20020031823.pdf [firstpage_image] =>[orig_patent_app_number] => 09873486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6096572 [patent_doc_number] => 20020052321 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-02 [patent_title] => 'Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof' [patent_app_type] => new [patent_app_number] => 09/872503 [patent_app_country] => US [patent_app_date] => 2001-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11220 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20020052321.pdf [firstpage_image] =>[orig_patent_app_number] => 09872503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1342642 [patent_doc_number] => 06582693 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-06-24 [patent_title] => 'Recombinant MVA virus expressing the E2 gene of Bovine papillomavirus and its use in the therapy of tumors generated by papillomaviruses' [patent_app_type] => B2 [patent_app_number] => 09/866726 [patent_app_country] => US [patent_app_date] => 2001-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 9477 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/582/06582693.pdf [firstpage_image] =>[orig_patent_app_number] => 09866726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6110452 [patent_doc_number] => 20020172689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-21 [patent_title] => 'Enhancement of oligomeric viral immunogenicity' [patent_app_type] => new [patent_app_number] => 09/861340 [patent_app_country] => US [patent_app_date] => 2001-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5620 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20020172689.pdf [firstpage_image] =>[orig_patent_app_number] => 09861340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6692523 [patent_doc_number] => 20030039955 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-27 [patent_title] => 'Compositions and methods for production of RNA viruses and RNA virus-based vector particles' [patent_app_type] => new [patent_app_number] => 09/853745 [patent_app_country] => US [patent_app_date] => 2001-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13219 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20030039955.pdf [firstpage_image] =>[orig_patent_app_number] => 09853745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 668168 [patent_doc_number] => 07094406 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-22 [patent_title] => 'Enterically transmitted non-A/non-B hepatitis viral agent and characteristic epitopes thereof' [patent_app_type] => utility [patent_app_number] => 09/851410 [patent_app_country] => US [patent_app_date] => 2001-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22550 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/094/07094406.pdf [firstpage_image] =>[orig_patent_app_number] => 09851410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 946437 [patent_doc_number] => 06964769 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-11-15 [patent_title] => 'Molecular antigen array' [patent_app_type] => utility [patent_app_number] => 09/848616 [patent_app_country] => US [patent_app_date] => 2001-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 46452 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 237 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/964/06964769.pdf [firstpage_image] =>[orig_patent_app_number] => 09848616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1323577 [patent_doc_number] => 06602697 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-05 [patent_title] => 'Process for purifying human papillomavirus virus-like particles' [patent_app_type] => B1 [patent_app_number] => 09/762662 [patent_app_country] => US [patent_app_date] => 2001-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4094 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/602/06602697.pdf [firstpage_image] =>[orig_patent_app_number] => 09762662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1199380 [patent_doc_number] => 06723325 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-20 [patent_title] => 'Smallpox vaccine' [patent_app_type] => B1 [patent_app_number] => 09/840751 [patent_app_country] => US [patent_app_date] => 2001-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4446 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/723/06723325.pdf [firstpage_image] =>[orig_patent_app_number] => 09840751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1208389 [patent_doc_number] => 06713067 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-03-30 [patent_title] => 'Herpes viruses for immune modulation' [patent_app_type] => B2 [patent_app_number] => 09/833073 [patent_app_country] => US [patent_app_date] => 2001-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9678 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/713/06713067.pdf [firstpage_image] =>[orig_patent_app_number] => 09833073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6405464 [patent_doc_number] => 20020037575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-28 [patent_title] => 'Recombinant virus vectors' [patent_app_type] => new [patent_app_number] => 09/833206 [patent_app_country] => US [patent_app_date] => 2001-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6262 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20020037575.pdf [firstpage_image] =>[orig_patent_app_number] => 09833206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1286637 [patent_doc_number] => 06635416 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-10-21 [patent_title] => 'Screening methods for identifying viral proteins with interferon antagonizing functions and potential antiviral agents' [patent_app_type] => B2 [patent_app_number] => 09/829711 [patent_app_country] => US [patent_app_date] => 2001-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 19975 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/635/06635416.pdf [firstpage_image] =>[orig_patent_app_number] => 09829711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6779357 [patent_doc_number] => 20030050439 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Self-assembling recombinant papilloma virus capsid proteins' [patent_app_type] => new [patent_app_number] => 09/832065 [patent_app_country] => US [patent_app_date] => 2001-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8501 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20030050439.pdf [firstpage_image] =>[orig_patent_app_number] => 09832065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1134800 [patent_doc_number] => 06784164 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-31 [patent_title] => 'Choline binding proteins for anti-pneumococcal vaccines' [patent_app_type] => B2 [patent_app_number] => 09/829382 [patent_app_country] => US [patent_app_date] => 2001-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 19 [patent_no_of_words] => 28011 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/784/06784164.pdf [firstpage_image] =>[orig_patent_app_number] => 09829382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6433368 [patent_doc_number] => 20020127675 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins' [patent_app_type] => new [patent_app_number] => 09/815079 [patent_app_country] => US [patent_app_date] => 2001-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 24113 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20020127675.pdf [firstpage_image] =>[orig_patent_app_number] => 09815079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6893833 [patent_doc_number] => 20010016199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-23 [patent_title] => 'Alphavirus RNA replicon systems' [patent_app_type] => new [patent_app_number] => 09/803600 [patent_app_country] => US [patent_app_date] => 2001-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9078 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20010016199.pdf [firstpage_image] =>[orig_patent_app_number] => 09803600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6442174 [patent_doc_number] => 20020176871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-28 [patent_title] => 'DNA vaccines against poxviruses' [patent_app_type] => new [patent_app_number] => 09/800632 [patent_app_country] => US [patent_app_date] => 2001-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 11836 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20020176871.pdf [firstpage_image] =>[orig_patent_app_number] => 09800632 [rel_patent_id] =>[rel_patent_doc_number] =>)